Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Genesis Gp Llc Orbimed currently holds 45,057 shares of Compass Therapeutics, Inc. (CMPX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Genesis Gp Llc Orbimed has been a net seller of CMPX stock. They have purchased $54.3M and sold $94.1M worth of shares.
Genesis Gp Llc Orbimed's most recent insider trade was on Nov 21, 2025, when they sold 74,465 shares at $17.75 per share.
Genesis Gp Llc Orbimed serves as Executive at Compass Therapeutics, Inc. (CMPX). They have executed 77 insider transactions totaling $148.4M over their tenure at the company.
Genesis Gp Llc Orbimed holds the position of Executive at Compass Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Genesis Gp Llc Orbimed has shown a selling trading pattern, with $54.3M in total purchases and $94.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Genesis Gp Llc Orbimed was on Dec 28, 2023, when they sold $21.9M worth of ALPN shares. This transaction involved 1,195,683 shares at $18.32 per share.
Genesis Gp Llc Orbimed currently owns 45,057 shares of Compass Therapeutics, Inc. (CMPX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Genesis Gp Llc Orbimed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Genesis Gp Llc Orbimed has 77 Form 4 filings on record as an insider at Compass Therapeutics, Inc..
Set alerts for Genesis Gp Llc Orbimed and 40,000+ other insiders.